Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation.

Haematologica

Volumn 92, Issue 11, 2007, Pages

  Helbig, G ^a   Stella Holowiecka, B ^b   Majewski, M ^b   Lewandowska, M ^b   Holowiecki, J ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; JANUS KINASE 2;

ARTICLE; CASE REPORT; CHRONIC DISEASE; GENETICS; HUMAN; HYPEREOSINOPHILIC SYNDROME; MALE; MIDDLE AGED; POINT MUTATION; TREATMENT OUTCOME;

CHRONIC DISEASE; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERFERON ALFA-2A; JANUS KINASE 2; MALE; MIDDLE AGED; POINT MUTATION; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 47649099919     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.11841     Document Type: Article

References (0)